medline.ch Respirationstrakt Neoplasie

	Frontline sigvotatug vedotin plus pembrolizumab vs pembrolizumab for non-small cell lung cancer with PD-L1 tumor proportion score â‰¥50%: phase III study design. Future Oncol Reck M, Lu S, O'Byrne KJ, Barrios C, Pavlov D, Tay F, Negrao MV. PMID: 41388832 [PubMed - as supplied by publisher]
	Associations of diabetes status, duration, and onset age with the risk of lung cancer: Results from the China Kadoorie Biobank study. Int J Cancer Su J, Hua J, Fan X, Wan X, Lu Y, Jin J, Hua Y, Pei P, Sun D, Yu C, Lv J, Wu M, Zhou J, Tao R. PMID: 41388620 [PubMed - as supplied by publisher]
	Microflora: a promising potential in the diagnosis and treatment of non-small cell lung cancer. Int J Clin Oncol Wang L, Chi Y, Zhang M, Jiang J, Meng Z, Wang Z. PMID: 41388199 [PubMed - as supplied by publisher]
	Prognostic Implications of SMARCA4, ARID1A, and Other BAF Mutations in Non-Small Cell Lung Cancer. Cancer Med Khalil A, Collins MP, Quintás-Cardama A. PMID: 41387924 [PubMed - indexed for MEDLINE]
	Clinical study of separation surgery combined with intraoperative vertebroplasty and (125)I seeds implantation for spinal metastases from lung adenocarcinoma with epidural spinal cord compression. World J Surg Oncol Zhang Y, Fan B, Wang T, Yang Y, Ui Haq NZ, Huang Z, Xu D, Liu Y, Li D, Han L, Wang W, Cai L, Yang X, Sun H, Zhang J, Wang C, Yuan T, Ma X, Yang Z. PMID: 41387879 [PubMed - as supplied by publisher]
	Tumor immune microenvironment score predicts efficacy of immune checkpoint inhibitors-based regimens in advanced non-small cell lung cancer. J Transl Med Dai J, Yan H, Chen Y, Zhang Y, Huang Z, Ruan Z, Tian F, Qin H, Xu Q, Wang J, Li X, Cheng P, Zhu C, Yang N, Zeng L, Zhang Y. PMID: 41387877 [PubMed - indexed for MEDLINE]
	Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial. Nat Commun Arrieta O, Lara-Mejía L, Rios-Garcia E, Caballé-Perez E, Cabrera-Miranda L, Ramos-Ramírez M, Dávila-Dupont D, Cardona AF, Cruz-Rico G, Remon J, Garcilazo-Reyes A, Rosell R. PMID: 41387445 [PubMed - in process]
	Investigating the role of oncogenic FAM83A as a prognostic biomarker in lung adenocarcinoma: Insights from smoker and non-smoker cohorts. J Genet Eng Biotechnol Singh P, Rathi A, Masood M, Hassan MI, Haque MM, Dohare R, Shamsi A. PMID: 41386847 [PubMed]
	Two-year Lung Cancer Incidence Among Patients Who Receive a Radiologist Recommendation for Chest CT in Neck CT and MRI Reports. J Am Coll Radiol Hassanzadeh M, Lee H, Lacson R, Hammer MM, Haneuse S, Khorasani R, Guenette JP. PMID: 41386541 [PubMed - as supplied by publisher]
	Impact of chronic lung disease, socioeconomic status, and family history on lung cancer risk in never-smokers: a matched case-control study. Chest Kwak HS, Lee J, Choi CM, Jung YJ, Kim HR, Hwang JH, Lee JY, Kim HK, Ji W. PMID: 41386456 [PubMed - as supplied by publisher]
	Consolidative thoracic radiotherapy in the immunotherapy era for extensive-stage small cell lung cancer: a systematic review and meta-analysis with emphasis on brain and liver metastases. Radiother Oncol Wróbel D, Wojewoda B, Zió, Potocki P, Borowczak J. PMID: 41386338 [PubMed - as supplied by publisher]
	Advances in Invasive Diagnostics in Lung Cancer. Semin Respir Crit Care Med Roy P, Shadchehr S, Gonzalez A. PMID: 41386288 [PubMed - as supplied by publisher]
	Are ultrasensitive ctDNA assays ready for clinical use in early-stage NSCLC? Cell Khan S, Li JJN, Leighl NB. PMID: 41386218 [PubMed - indexed for MEDLINE]
	mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review). Int J Oncol Pang X, Liu H, Long Y, Wang H. PMID: 41384305 [PubMed - indexed for MEDLINE]
	Pulmonary Benign Metastasizing Leiomyoma in a Patient With a Concurrent Breast Tumor: A Diagnostic Challenge. Cureus Araya T, Kita T, Higashi T, Hara R, Takato H. PMID: 41384190 [PubMed]
	Development of a machine learning model for preoperative prediction of spread through air spaces in resectableÂ non-small cell lung cancer: A single-center retrospective study. Oncol Lett Yang C, Ding G, Zhan B, Xuan L, Cheng F, Yang Y. PMID: 41383980 [PubMed]
	Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling. Front Immunol Liu J, Zhu X, Zha C, Ding J, Zhang C, Wang Y, Yan T, Kong H, Liu Y, Chen J. PMID: 41383634 [PubMed - indexed for MEDLINE]
	Platelets and platelet-derived extracellular vesicles: their role in lung cancer dissemination and premetastatic niche formation. Front Immunol Locatelli C, Ferrario N, Fortunato O, Ghidotti P, Crescitelli R. PMID: 41383620 [PubMed - indexed for MEDLINE]
	Single center experience of the impact of artificial intelligence image analysis software on short-term prognosis of non-small cell lung cancer. Front Oncol Chang L, Dong S, Kadeer A, Song S, Guo T, Liu F. PMID: 41383517 [PubMed]
	CXCR4-targeted therapy in lung cancer: plerixafor as a promising antimetastatic agent. Front Pharmacol Ramalingam PS, Afzal M, Babu MA, Rekha MM, Sahoo S, Pandey SN, Goyal K, Hussain MS, Gupta G, Balakrishnan P, Arumugam S. PMID: 41383468 [PubMed]

Artikel 1 - 20 / 155703

Seite 1 von 7786



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung